If you need more lookups,
subscriptions start at $34 USD/month.
Steve Dingman Location
Cambridge, MA, US
Steve Dingman Work
Vice President, Pharmacovigilance, Head of Safety @ (October 2024 - Present)
Vice President, Pharmacovigilance at ImmunoGen @ (September 2022 - June 2024)
Vice President, Drug Safety and Pharmacovigilance @ (July 2019 - September 2022)
Senior Medical Director @ (November 2017 - July 2019)
Senior Medical Director, Global Pharmacovigilance @ (July 2011 - November 2017)
Steve Dingman Education
University of Iowa
BA (Finance)
North Carolina State University
BA (Chemistry)
The University of North Carolina at Chapel Hill
MD
Steve Dingman Skills
Biotechnology
CRO
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Drug Safety
GCP
Medical Affairs
Medicine
Oncology
Pharmaceutical Industry
Pharmacovigilance
Regulatory Affairs
Regulatory Submissions
Leadership
Customer Service
Steve Dingman Summary
Steve Dingman, based in Cambridge, MA, US, is currently a Vice President, Pharmacovigilance, Head of Safety at Merus N.V.. Steve Dingman brings experience from previous roles at ImmunoGen, Inc., Alkermes, Clovis Oncology and AbbVie. Steve Dingman holds a BA in Finance @ University of Iowa. With a robust skill set that includes Biotechnology, CRO, Clinical Development, Clinical Research, Clinical Trials and more. Steve Dingman has 2 emails on RocketReach.
Looking for a different Steve Dingman?
Find contact details for 700 million professionals.